Format

Send to

Choose Destination
See comment in PubMed Commons below
Herz. 2008 Feb;33(1):52-8. doi: 10.1007/s00059-008-3087-3.

[Anticoagulant therapy in venous thromboembolism].

[Article in German]

Author information

1
Arbeitsbereich Angiologie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden.

Abstract

Venous thromboembolism (VTE) is a common cause of morbidity and mortality with an estimated annual incidence of 1 : 1,000. Patients show individual risk profiles with regard to recurrent VTE and treatment-associated bleeding, which are characterized by the presence of endogenous factors (such as hereditary thrombophilic disorders), but much more by exogenous factors (underlying disease). This results in risk-adapted therapeutic recommendations, which will be discussed in the following review.

PMID:
18273578
DOI:
10.1007/s00059-008-3087-3
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center